Procter & Gamble Health Ltd - Announcement under Regulation 30 (LODR)-Change in Directorate

| Updated on June 28, 2019 Published on June 28, 2019

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that Mr. Sujay Wasan has been appointed as Additional (Non-Executive) Director of the Company subject to and effective from date of allotment of Director Identification Number (DIN). Mr. Sujay Wasan is not related to any Director of the Company.

Brief profile of Mr. Sujay Wasan is given below:

Mr. Sujay Wasan holds an International Masters in Business Administration degree (MBA) from The Netherlands. Mr. Sujay Wasan is the Vice President-Asia, India, Middle East and Africa, Personal Healthcare and Oral care, Asia Pacific and has lived and worked across Western Europe, North America and Asia with rich brand building experience across multiple core categories in critical global, regional and country roles. Mr. Sujay Wasan has spent the last 15 years with P&G with assignments spanning global marketing and strategy for multi-billion dollar brands, designing breakthrough innovation, category marketing, and country operations with focus on purpose led marketing programs, digital and store-back marketing.

Mr. Sujay Wasan is not debarred or disqualified from holding the office of Director by virtue of any order from SEBI / MCA or any such statutory authority.

Kindly take the same on record.

Pdf Link: Procter & Gamble Health Ltd - Announcement under Regulation 30 (LODR)-Change in Directorate

Source : BSE - www.bseindia.com

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on June 28, 2019
This article is closed for comments.
Please Email the Editor